× Business BUSINESS MOTORING SHIPPING & LOGISTICS DR PESA FINANCIAL STANDARD Digital News Videos Health & Science Lifestyle Opinion Education Columnists Moi Cabinets Arts & Culture Fact Check Podcasts E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise VAS E-Learning Digger Classified Jobs Games Crosswords Sudoku The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
×

Alarm as 10 HIV drugs out of stock

HEALTH & SCIENCE
By Anyango Otieno and Graham Kajilwa | Oct 7th 2020 | 1 min read
By Anyango Otieno and Graham Kajilwa | October 7th 2020
HEALTH & SCIENCE

 

There is a shortage of 10 crucial HIV/Aids drugs as a result of Covid-19 pandemic, the UN has warned.

In a latest report by UNAids, at least 10 anti-retroviral therapy (ART) medication is in short supply.

They include Tenofovir, Abacavuir, Cotrimoxazole suspension, Ritonavir tablets, Nevirapine suspension (for new born), Zidovudine solution, Zidovudine/lamivudine (AZT/3TC), Lopinavir/ Ritonavir(LPV/r) 100/25 mg, and LPV/r pellets 40/10 formulation.

A model by the World Health Organisation and the Joint United Nations Programmes on HIV and Aids (UNAids) estimated a six-month disruption of antiretroviral therapy could lead to more than 500 000 additional Aids-related deaths, including from tuberculosis, in sub-Saharan Africa in 2020–2021.

In Kenya, persons living with HIV have already confirmed a short supply of Cotrimoxazole, which is sold as Septrin.

Share this story
Who pays for the toilet paper? The big questions of the work-from-home era
Surely it makes perfect sense for a boss to cough up for a productivity-enhancing cappuccino machine?
China rejected Kenya's request for Sh32.8b debt moratorium
China is Kenya’s largest bilateral lender with an outstanding debt of Sh692 billion.
.
RECOMMENDED NEWS
Feedback